CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab.

CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab.

Item
http://www.wikidata.org/entity/Q34038915
Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994-2004.Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review.First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation.Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation.Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels.Posttransplant Lymphoproliferative Disorder after Cardiac Transplantation in Children: Life Threatening Complications Associated with Chemotherapy Combined with Rituximab
P2860

CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab.

Item
http://www.wikidata.org/entity/Q34038915
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
CD-20 expression in post-trans ...... ers: treatment with rituximab.
@ast
CD-20 expression in post-trans ...... ers: treatment with rituximab.
@en
CD-20 expression in post-trans ...... ers: treatment with rituximab.
@nl
type
label
CD-20 expression in post-trans ...... ers: treatment with rituximab.
@ast
CD-20 expression in post-trans ...... ers: treatment with rituximab.
@en
CD-20 expression in post-trans ...... ers: treatment with rituximab.
@nl
prefLabel
CD-20 expression in post-trans ...... ers: treatment with rituximab.
@ast
CD-20 expression in post-trans ...... ers: treatment with rituximab.
@en
CD-20 expression in post-trans ...... ers: treatment with rituximab.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
CD-20 expression in post-trans ...... ers: treatment with rituximab.
@en
P2093
P2860
P304
P31
P356
10.1002/1096-8652(200010)65:2<171::AID-AJH14>3.0.CO;2-Z
P433
P478
P577
P698